myristic acid has been researched along with Carcinoma, Non-Small Cell Lung in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gotoh, N; Huang, L; Iejima, D; Kuroda, M; Minegishi, Y; Siswanto, A; Takenaka, K; Tanaka, F; Watanabe, M; Watanabe, T | 1 |
| Atkinson, EN; Carboni, G; Ji, L; Kondo, M; Minna, JD; Nishizaki, M; Roth, JA; Sasaki, J; Uno, F; Xu, K | 1 |
2 other study(ies) available for myristic acid and Carcinoma, Non-Small Cell Lung
| Article | Year |
|---|---|
FRS2beta, a potential prognostic gene for non-small cell lung cancer, encodes a feedback inhibitor of EGF receptor family members by ERK binding.
Topics: Adaptor Proteins, Signal Transducing; Carcinoma, Non-Small-Cell Lung; Cell Culture Techniques; Cell Division; Cell Membrane; Colony-Forming Units Assay; Enzyme Activation; Epidermal Growth Factor; ErbB Receptors; Extracellular Signal-Regulated MAP Kinases; Gene Expression Regulation, Neoplastic; Humans; Kinetics; Lung Neoplasms; Mitogen-Activated Protein Kinase 3; Myristic Acid; Prognosis; Protein Binding; RNA, Messenger | 2010 |
Myristoylation of the fus1 protein is required for tumor suppression in human lung cancer cells.
Topics: Animals; Carcinoma, Non-Small-Cell Lung; Cell Line, Tumor; Genes, Tumor Suppressor; Humans; Lung Neoplasms; Mice; Mice, Nude; Myristic Acid; Protein Precursors; Protein Processing, Post-Translational; Subcellular Fractions; Tumor Suppressor Proteins; Ubiquitins | 2004 |